Insider Transactions in Q2 2023 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2023
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.0%
|
$20,000
$2.08 P/Share
|
|
May 22
2023
|
Jeremy G Chadwick Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+50.0%
|
-
|